×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OLMA – olema pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OLMA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/13
01:45 pm
olma
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Medium
Report
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
11/12
04:12 pm
olma
Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/12
04:01 pm
olma
Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/6
07:01 am
olma
Olema Oncology to Participate in Upcoming Investor Conferences
Medium
Report
Olema Oncology to Participate in Upcoming Investor Conferences
11/4
04:44 pm
olma
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/24
08:08 am
olma
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
10/23
07:00 am
olma
Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024
Medium
Report
Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024
10/9
07:00 am
olma
Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Low
Report
Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Date
Time
Symbol
Headline
Impact
11/14
04:35 pm
olma
Form SC 13G/A Olema Pharmaceuticals, Filed by: Paradigm Biocapital Advisors LP
High
Report
Form SC 13G/A Olema Pharmaceuticals, Filed by: Paradigm Biocapital Advisors LP
11/14
09:20 am
olma
Form SC 13G/A Olema Pharmaceuticals, Filed by: Deep Track Capital, LP
High
Report
Form SC 13G/A Olema Pharmaceuticals, Filed by: Deep Track Capital, LP
11/12
04:16 pm
olma
Form 10-Q Olema Pharmaceuticals, For: Sep 30
Low
Report
Form 10-Q Olema Pharmaceuticals, For: Sep 30
11/12
04:11 pm
olma
Form 8-K Olema Pharmaceuticals, For: Nov 12
Low
Report
Form 8-K Olema Pharmaceuticals, For: Nov 12
9/27
07:01 am
olma
Form 8-K Olema Pharmaceuticals, For: Sep 27
Low
Report
Form 8-K Olema Pharmaceuticals, For: Sep 27
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: